Carbon monoxide is a poison ... to microbes! CO as a bactericidal molecule

Current Opinion in Pharmacology

Volumn 9, Issue 4, 2009, Pages 490-500

  Chin, Beek Yoke ^a   Otterbein, Leo E ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; BCG VACCINE; CARBON MONOXIDE; REACTIVE OXYGEN METABOLITE;

ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; DRUG MECHANISM; DRUG POTENCY; DRUG PROTEIN BINDING; ENVIRONMENTAL FACTOR; HEMORRHAGIC SHOCK; HOST RESISTANCE; HUMAN; HYPOXEMIA; INNATE IMMUNITY; LUNG INJURY; MALARIA; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PLASMODIUM BERGHEI; PRIORITY JOURNAL; REVIEW; SEPSIS; TUBERCULOSIS;

ANIMALS; ANTI-INFECTIVE AGENTS; CARBON MONOXIDE; CARBON MONOXIDE POISONING; HUMANS; INFLAMMATION; MYCOBACTERIUM TUBERCULOSIS;

EID: 68849092035     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2009.06.025     Document Type: Review

References (77)

1. Kombe G.C., and Darrow D.M. Revisiting emerging infectious diseases: the unfinished agenda. J Community Health 26 (2000) 113-122
2. Mokdad A.H., Marks J.S., Strop D.F., and Gerberding J.L. Actual causes of death in the United States. JAMA 291 (2000) 1238-1245
3. Pieters J. Mycobacterium tuberculosis and the macrophage: maintaining a balance. Cell Host Microbe 3 (2008) 399-407
4. Pinsky M.R. Sepsis: a pro- and anti-inflammatory disequilibrium syndrome. Contrib Nephrol 132 (2001) 354-366
5. Elson G., Dunn-Siegrist I., Daubeuf B., and Pugin J. Contribution of Toll-like receptors to the innate immune response to Gram-negative and Gram-positive bacteria. Blood 109 (2007) 1574-1583
6. Underhill D.M., and Ozinsky A. Phagocytosis of microbes: complexity in action. Annu Rev Immunol 20 (2002) 825-852. An excellent and complete introduction to the innate functions of macrophages and neutrophils.
7. Ryter S.W., Alam J., and Choi A.M.K. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic implications. Physiol Rev 86 (2006) 583-650. This is the most comprehensive review, to date, on the role of heme oxygenase-1 (HO-1) as an endogenous protective molecule. I highly recommend this review as an introduction to HO-1 function as the authors have compiled an exhaustive account of HO-1 and it is most celebrated catabolite, carbon monoxide (CO) in alleviating models of clinical disease.
8. Tenhunen R., Marver H.S., and Schmidt R. The enzymatic catabolism of hemoglobin: stimulation of microsomal heme oxygenase by hemin. J Lab Clin Med 75 (1970) 410-421
9. Otterbein L.E., and Soares M.P. Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol 24 (2003) 449-455
10. Wiesel P., Patel A.P., DiFonzo N., Marria P.B., Sim C.U., Pellacani A., Maemura K., LeBlanc B.W., Marino K., Doerschuk C.M., et al. Endotoxin-induced mortality is related to increased oxidative stress and end-organ dysfunction, not refractory hypotension, in heme oxygenase-1-deficient mice. Circulation 102 (2000) 3015-3022
11. Otterbein L.E., Bach F.H., Alam J., Soares M., Tao Lu H., Wysk M., Davis R.J., Flavell R.A., and Choi A.M. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 6 (2000) 422-428. This seminal manuscript describes the potency of inhaled carbon monoxide (iCO) as an anti-inflammatory molecule in a murine model of sepsis. A landmark finding that paved the way for iCO as a therapeutic.
12. Desmard M., Davidge K.S., Bouvet O., Morin D., Roux D., Foresti R., Ricard J.D., Denamur E., Poole R.K., Montravers P., et al. A carbon monoxide-releasing molecule (CORM-3) exerts bactericidal activity against Pseudomonas aeruginosa and improves survival in an animal model of bacteraemia. FASEB J 4 (2009) 1023-1031
13. Sweeney M.T., and Zurenko G.E. In vitro activities of linezolid combined with other antimicrobial agents against Staphylococci, Enterococci, Pneumococci, and selected Gram-negative organisms. Antimicrob Agents Chemother 47 (2003) 1902-1906
14. Sarady J.K., Zuckerbraun B.S., Bilban M., Wagner O., Usheva A., Liu F., Ifedigbo E., Zamora R., Choi A.M., and Otterbein L.E. Carbon monoxide in the lung and liver. FASEB J 18 (2004) 854-856
15. Cepinskas G., Katada K., Bihari A., and Potter R.F. Carbon monoxide liberated from carbon monoxide-releasing molecule CORM-2 attenuates inflammation in the liver of septic mice. Am J Physiol Gastrointest Liver Physiol 294 (2008) G184-G191
16. Dye C. Doomsday postponed? Preventing and reversing epidemics of drug-resistant tuberculosis. Nat Rev Microbiol 7 (2009) 81-87
17. White N.J. The role of anti-malarial drugs in eliminating malaria. Malar J 7 Suppl 1 (2008) S8
18. Chung S.W., Liu X., Macias A.A., Baron R.M., and Perrella M.A. Heme oxygenase-1-derived carbon monoxide enhances the host defense response to microbial sepsis in mice. J Clin Invest 118 (2008) 239-247
19. Chung S.W., Hall S.R., and Perrella M.A. Role of heme oxygenase-1 in microbial host defense. Cell Microbiol 2 (2009) 199-202. This is a fairly recent and meticulous review of the role of heme oxygenase-1 (HO-1) as a novel host defense molecule. The effect of HO-1 on modulating bacterial, fungal, viral and parasitic activity is discussed.
20. Haldane J. The action of carbonic oxide on man. J Physiol (London) 18 (1895) 430-462
21. Haldane J.B.S. Carbon monoxide as a tissue poison. Biochem J 21 (1927) 1068-1075
22. Zuckerbraun B.S., McCloskey C.A., Gallo D., Liu F., Ifedigbo E., Otterbein L.E., and Billiar T.R. Carbon monoxide prevents multiple organ injury in a model of hemorrhagic shock and resuscitation. Shock 23 (2005) 527-532
23. Fujita T., Toda K., Karimova A., Yan S.F., Naka Y., Yet S.F., and Pinsky D.J. Paradoxical rescue from ischemic lung injury by inhaled carbon monoxide driven by derepression of fibrinolysis. Nat Med 7 (2001) 598-604
24. Eastbrook R.W., Franklin M.R., and Hildebrandt A.G. Factors influencing the inhibitory effect of carbon monoxide on cytochrome p-450-catalyzed mixed function oxidation reactions. Ann NY Acad Sci 174 (1970) 218-232
25. Volpe J.A., O'Toole M.C., and Caughey W.S. Quantitative infrared spectroscopy of CO complexes of Cytochrome c oxidase, hemoglobin and myoglobin: Evidence for one CO per heme. Biochem Biophys Res Commun 62 (1975) 48-53
26. Furchgott R.F., and Jothianandan D. Endothelium-dependent and -independent vasodilation involving cyclic GMP: relaxation induced by nitric oxide, carbon monoxide and light. Blood Vessels 28 (1991) 52-61. One of the seminal papers describing a biochemical target and function for carbon monoxide (CO).
27. Collman J.P., Brauman J.I., Halbert T.R., and Suslick K.S. Nature of O2 and CO binding to metalloporphyrins and heme proteins. Proc Natl Acad Sci U S A 73 (1976) 3333-3337
28. Cobrun R.F. The carbon monoxide body stores. Ann NY Acad Sci 174 (1970) 255-260
29. Marks G.S., Vreman H.J., McLaughlin B.E., Brien J.F., and Nakatsu K. Measurement of endogenous carbon monoxide formation in biological systems. Antioxid Redox Signal 4 (2002) 271-277
30. Zegdi R., Perrin D., Burdin M., Boiteau R., and Tenaillon A. Increased endogenous carbon monoxide production in severe sepsis. Intensive Care Med 28 (2002) 793-796
31. Shi Y., Pan F., Li H., Pan J., Qin S., Jiang D., and Shen C. Carbon monoxide concentrations in paediatric sepsis syndrome. Arch Dis Child 88 (2003) 889-890
32. Machado R.F., Reda D., Tropea M., Gladwin M.T., and Suffrendini A.F. The effects of inhaled carbon monoxide on endotoxin-induced pulmonary inflammation in humans. Am J Respir Crit Care Med 179 (2009) A5673
33. Alonso J.R., Cardellach F., López S., Casademont J., and Miró O. Carbon monoxide specifically inhibits Cytochrome c oxidase of human mitochondrial respiratory chain. Pharmacol Toxicol 93 (2003) 142-146
34. Taskiran D., Nesil T., and Alkan K. Mitochondrial oxidative stress in female and male rat brain after ex vivo carbon monoxide treatment. Hum Exp Toxicol 26 (2007) 645-651
35. Chin B.Y., Jiang G., Wegiel B., Wang H.J., Macdonald T., Zhang X.C., Gallo D., Cszimadia E., Bach F.H., Lee P.J., and Otterbein L.E. Hypoxia-inducible factor 1alpha stabilization by carbon monoxide results in cytoprotective preconditioning. Proc Natl Acad Sci U S A 104 (2007) 5109-5114. This is one of the first reports detailing the rapid 'physiological effect' of exogenous administration of carbon monoxide (CO); release of reactive oxygen species (ROS) from the mitochondria in cultured macrophages. Additionally, exogenous CO-derived ROS were documented to induce and stabilize HIF1α in unstimulated macrophages as a prelude to confer cytoprotection.
36. Zuckerbraun B.S., Chin B.Y., Bilban M., d'Avila J.C., Rao J., Billiar T.R., and Otterbein L.E. Carbon monoxide signals via inhibition of Cytochrome c oxidase and generation of mitochondrial reactive oxygen species. FASEB J 21 (2007) 1099-1106
37. Scragg J.L., Dallas M.L., Wilkinson J.A., Varadi G., and Peers C. Carbon monoxide inhibits L-type Ca2+ channels via redox modulation of key cysteine residues by mitochondrial reactive oxygen species. J Biol Chem 283 (2008) 24412-24419
38. Coburn R.F., Blakemore W.S., and Forster R.E. Endogenous carbon monoxide production in man. J Clin Invest 42 (1963) 1172-1178
39. Von Berg R. Toxicology update. Carbon monoxide. J Appl Toxicol 19 (1999) 379-386
40. Boehning D., and Snyder S.H. Novel neural modulators. Annu Rev Neurosci 26 (2003) 105-131
41. Ingi T., Chiang G., and Ronnett G.V. The regulation of heme turnover and carbon monoxide biosynthesis in cultured primary rat olfactory receptor neurons. J Neurosci 16 (1996) 5621-5628
42. Shiloh M.U., Manzanillo P., and Cox J.S. Mycobacterium tuberculosis senses host-derived carbon monoxide during macrophage infection. Cell Host Microbe 3 (2008) 323-330
43. •], this seminal report describes the endogenous neural function of heme-oxygenase derived CO.
44. Amersi F., Shen X.D., Anselmo D., Melinek J., Iyer S., Southard D.J., Katori M., Volk H.D., Busuttil R.W., Buelow R., and Kupiec-Weglinski J.W. Ex vivo exposure to carbon monoxide prevents hepatic ischemia/reperfusion injury through p38 MAP kinase pathway. Hepatology 35 (2002) 815-823
45. Bilban M., Bach F.H., Otterbein S.L., Ifedigbo E., d'Avila J.C., Esterbauer H., Chin B.Y., Usheva A., Robson S.C., Wagner O., and Otterbein L.E. Carbon monoxide orchestrates a protective response through PPARgamma. Immunity 24 (2006) 601-610
46. Zhang X., Shan P., Alam J., Fu X.Y., and Lee P.J. Carbon monoxide differentially modulates STAT1 and STAT3 and inhibits apoptosis via a phosphatidylinositol 3-kinase/Akt and p38 kinase-dependent STAT3 pathway during anoxia-reoxygenation injury. J Biol Chem 280 (2005) 8714-8721
47. Li A., Xi Q., Umstot E.S., Bellner L., Schwartzman M.L., Jaggar J.H., and Leffler C.W. Astrocyte-derived CO is a diffusible messenger that mediates glutamate-induced cerebral arteriolar dilation by activating smooth muscle Cell KCa channels. Circ Res 102 (2008) 234-241
48. Taillé C., El-Benna J., Lanone S., Boczkowski J., and Motterlini R. Mitochondrial respiratory chain and NAD(P)H oxidase are targets for the antiproliferative effect of carbon monoxide in human airway smooth muscle. J Biol Chem 280 (2005) 25350-25360
49. Foresti R., Bani-Hani M.G., and Motterlini R. Use of carbon monoxide as a therapeutic agent: promises and challenges. Intensive Care Med 4 (2008) 649-658. This is a brief but comprehensive review on the pleitropicity of carbon monoxide releasing molecules (CO-RMs) as a therapeutic. Structure and function of various CO-RM molecules are described. More importantly, a comparison between the efficacy of inhaled carbon monoxide and CO-RMs in established disease models is discussed.
50. Motterlini R., Sawle P., Hammad J., Bains S., Alberto R., Foresti R., and Green C.J. CORM-A1: a new pharmacologically active carbon monoxide-releasing molecule. FASEB J 19 (2005) 284-286
51. Davidge K.S., Sanguinetti G., Yee C.H., Cox A.G., McLeod C.W., Monk C.E., Mann B.E., Motterlini R., and Poole R.K. Carbon monoxide-releasing antibacterial molecules target respiration and global transcriptional regulators. J Biol Chem 284 (2009) 4516-4524
52. Martin G.S., Mannino D.M., Eaton S., and Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348 (2003) 1546-1554
53. Opal S.M., Garber G.E., LaRosa S.P., Maki D.G., Freebairn R.C., Kinasewitz G.T., Dhainaut J.F., Yan S.B., Williams M.D., Graham D.E., et al. Systemic host responses in severe sepsis analyzed by causative microorganism and treatment effects of drotrecogin alfa (activated). Clin Infect Dis 37 (2003) 50-58
54. Zhou H., Lu F., Latham C., Zander D.S., and Visner G.A. Heme oxygenase-1 expression in human lungs with cystic fibrosis and cytoprotective effects against Pseudomonas aeruginosa in vitro. Am J Respir Crit Care Med 170 (2004) 633-640
55. Ladan H., Nitzan Y., and Malik Z. The antibacterial activity of haemin compared with cobalt, zinc and magnesium protoporphyrin and its effect on potassium loss and ultrastructure of Staphylococcus aureus. FEMS Microbiol Lett 112 (1993) 173-177
56. Otterbein L.E., May A., and Chin B.Y. Carbon monoxide increases macrophage bacterial clearance through Toll-like receptor (TLR)4 expression. Cell Mol Biol 51 (2005) 433-440. This is one of first reports demonstrating the innate ability of exogenous CO in mediating bacterial clearance in macrophages, most specifically, the Gram-negative species of Escherichia coli.
57. Nobre L.S., Seixas J.D., Romão C.C., and Saraiva L.M. Antimicrobial action of carbon monoxide-releasing compounds. Antimicrob Agents Chemother 51 (2007) 4303-4307. This manuscript demonstrates first report of carbon monoxide, more specifically carbon monoxide releasing molecules (CO-RMs) as a bactericidal agent.
58. Overhaus M., Moore B.A., Barbato J.E., Behrendt F.F., Doering J.G., and Bauer A.J. Biliverdin protects against polymicrobial sepsis by modulating inflammatory mediators. Am J Physiol (Gastrointest Liver Physiol) 290 (2006) G295-G703
59. Brooks J.C., Alvarado M., Stephens T.P., Kellermeier J.D., Tittor A.W., Miller M.F., and Brashears M.M. Spoilage and safety characteristics of ground beef packaged in traditional and modified atmosphere packages. J Food Prot 71 (2008) 293-301
60. Desmard M., Davidge K.S., Bouvet O., Morin D., Roux D., Foresti R., Ricard J.D., Denamur E., Poole R.K., Montravers P., et al. A carbon monoxide-releasing molecule (CORM-3) exerts bactericidal activity against Pseudomonas aeruginosa and improves survival in an animal model of bacteraemia. FASEB J 23 (2009) 1023-1031
61. Suliman H.B., Carraway M.S., Tatro L.G., and Piantadosi C.A. A new activating role for CO in cardiac mitochondrial biogenesis. J Cell Sci 120 Pt 2 (2007) 299-308
62. Amino R., Thiberge S., Martin B., Celli S., Shorte S., Frischknecht F., and Menard R. Quantitative imaging of Plasmodium transmission from mosquito to mammal. Nat Med 12 (2006) 220-224
63. Frevert U., Engelmann S., Zougbede S., Stange J., Ng B., Matuschewski K., Liebes L., and Yee H. Intravital observation of Plasmodium berghei sporozoite infection of the liver. PLoS Biol 3 (2005) e192
64. Mota M.M., Pradel G., Vanderberg J.P., Hafalla J.C., Frevert U., Nussenzweig R.S., Nussenzweig V., and Rodríguez A. Migration of Plasmodium sporozoites through cells before infection. Science 291 (2001) 141-144
65. Baer K., Klotz C., Kappe S.H., Schnieder T., and Frevert U. Release of hepatic Plasmodium yoelii merozoites into the pulmonary microvasculature. PLoS Pathog 3 (2007) e171
66. Sturm A., Amino R., van de Sand C., Regen T., Retzlaff S., Rennenberg A., Krueger A., Pollok J.M., Menard R., and Heussler V.T. Manipulation of host hepatocytes by the malaria parasite for delivery into liver sinusoids. Science 313 (2006) 1287-1290
67. Lalor P.F., Shields P., Grant A., and Adams D.H. Recruitment of lymphocytes to the human liver. Immunol Cell Biol 80 (2002) 52-64
68. Pamplona A., Ferreira A., Balla J., Jeney V., Balla G., Epiphanio S., Chora A., Rodrigues C.D., Gregoire I.P., Cunha-Rodrigues M., et al. Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria. Nat Med 13 (2007) 703-710
69. Wayne L.G. Dormancy of Mycobacterium tuberculosis and latency of disease. Eur J Clin Microbiol Infect Dis 13 (1994) 908-914
70. Wayne L.G., and Sohaskey C.D. Nonreplicating persistence of Mycobacterium tuberculosis. Annu Rev Microbiol 55 (2001) 139-163
71. McDermott W. Inapparent infection. Relation of latent and dormant infections to microbial persistence. Public Health Rep 74 (1959) 485-499
72. Roberts D.M., Liao R.P., Wisedchaisri G., Hol W.G., and Sherman D.R. Two sensor kinases contribute to the hypoxic response of Mycobacterium tuberculosis. J Biol Chem 279 (2004) 23082-23087
73. Sherman D.R., Voskuil M., Schnappinger D., Liao R., Harrell M.I., and Schoolnik G.K. Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding alpha-crystallin. Proc Natl Acad Sci U S A 98 (2001) 7534-7539
74. Sousa E.H., Tuckerman J.R., Gonzalez G., and Gilles-Gonzalez M.A. DosT and DevS are oxygen-switched kinases in Mycobacterium tuberculosis. Protein Sci 16 (2007) 1708-1719
75. Ioanoviciu A., Yukl E.T., Moënne-Loccoz P., and de Montellano P.R. DevS, a heme-containing two-component oxygen sensor of Mycobacterium tuberculosis. Biochemistry 46 (2007) 4250-4260
76. Kumar A., Toledo J.C., Patel R.P., Lancaster Jr. J.R., and Steyn A.J. Mycobacterium tuberculosis DosS is a redox sensor and DosT is a hypoxia sensor. Proc Natl Acad Sci U S A 104 (2007) 11568-11573
77. Voskuil M.I., Schnappinger D., Visconti K.C., Harrell M.I., Dolganov G.M., Sherman D.R., and Schoolnik G.K. Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program. J Exp Med 198 (2003) 705-713